Ligand validation:2C10

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 2C10 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2C10_NAG_D_1770	38%	47%	0.175	0.876	0.68	1.33	-	2	0	0	100%	0.9333
2C10_NAG_D_1768	36%	44%	0.178	0.871	0.57	1.55	-	3	0	0	100%	0.9333
2C10_NAG_B_1768	36%	46%	0.178	0.87	0.53	1.51	-	1	0	0	100%	0.9333
2C10_NAG_C_1768	32%	62%	0.211	0.884	0.61	0.85	-	-	0	0	100%	0.9333
2C10_NAG_B_1773	29%	37%	0.172	0.843	0.61	1.82	-	4	1	0	93%	0.9333
2C10_NAG_B_1770	25%	20%	0.21	0.845	0.62	2.74	-	6	0	0	100%	0.9333
2C10_NAG_A_1768	22%	58%	0.234	0.851	0.52	1.06	-	2	1	0	100%	0.9333
2C10_NAG_D_1774	14%	43%	0.203	0.76	0.62	1.55	-	2	1	0	93%	0.9333
2C11_NAG_A_1734	100%	66%	0.027	0.989	0.67	0.63	-	-	4	0	100%	0.9333
4BTX_NAG_A_1768	40%	29%	0.16	0.87	0.88	1.93	-	5	1	0	100%	0.9333
4BTY_NAG_A_1767	32%	23%	0.195	0.869	0.83	2.28	-	7	0	0	100%	0.9333
3ALA_NAG_D_1775	25%	33%	0.192	0.824	0.69	1.93	-	4	0	0	100%	0.9333
1PU4_NAG_B_2781	23%	32%	0.273	0.897	0.98	1.68	1	5	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_A_601	100%	70%	0.024	0.993	0.3	0.85	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.